Complutense University of Madrid

Global Experts from SEPA Call for the Control of Gingivitis Rather than Waiting for Periodontitis to Develop

Retrieved on: 
Monday, April 8, 2024
CASA, Toothpaste, Head, Confusion, Tooth brushing, EFP, Journal of Clinical Periodontology, Patient, Quality of life, Complutense University of Madrid, UCM, Therapy, Dental, Oral hygiene, Etiology, United States of Europe, Risk, Education, Gingivitis, Treatment, Recurrence, Dentistry, Prevalence, Disease, Clinical, White paper, Public, Knowledge, Research, University, Overalls, University College London, Mouthwash, Dentist, Molina Healthcare, Health, Motivation, Incidence, Physician, British Dental Journal, Inflammation, Pharmacist, Plaque, Systematic review, Bleeding, S3, Meta-analysis

SEPA: Limited knowledge among oral health teams of the recommendations and evidence currently available on oral antiseptics (that are clinically proven to be effective) reduces their implementation; therefore, more practical and simple advice is proposed.

Key Points: 
  • This was highlighted at an International Summit of Experts held at the Casa de las Encías in Madrid, Spain, the headquarters of the SEPA Foundation.
  • "Periodontal diseases are prevalent worldwide, affecting hundreds of millions of people," says the meeting coordinator, Dr. Paula Matesanz, vice president of SEPA.
  • As Dr. Iain Chapple summarizes, "It is time for a paradigm shift: we must control gingivitis and not wait until periodontitis develops."
  • J Clin Periodontol 2022 Jun:49 Suppl 24:4-71 (version adapted by SEPA available at https://portal.guiasalud.es/gpc/tratamiento-periodontitis-estadio-iv )
    * Chapple I, Time to take gum disease seriously.

Greenwich LifeSciences Partners with GEICAM in Spain & Conducts First Site Initiation Visits in Europe

Retrieved on: 
Tuesday, March 12, 2024
Principal, GP2, Faculty, Breast cancer, Gregorio, Immunotherapy, Disease, Patient, Knowledge, GM-CSF, Research, Hospital, Observation, Pi, Cancer, Death, Teaching hospital, Baylor College of Medicine, ECIS, Complutense University of Madrid, Woman, Prognosis, Book, Vaccine, Map

The Company has partnered with GEICAM, the largest academic breast cancer research network in Spain, where 38 hospitals have agreed to participate in FLAMINGO-01.

Key Points: 
  • The Company has partnered with GEICAM, the largest academic breast cancer research network in Spain, where 38 hospitals have agreed to participate in FLAMINGO-01.
  • These sites were recently approved by Spanish authorities, which led to site initiation visits and training of the first sites this past week.
  • Founded in 1995, GEICAM is a not-for-profit organization leading academic breast cancer research in Spain.
  • Breast cancer is the leading cause of death in women between the ages 35-45 in Spain with 6,836 deaths in 2022.

LLYC reports revenue and EBITDA growth for 2023

Retrieved on: 
Thursday, March 21, 2024
Growth, Media, ESG, Corporate Affairs, Marketing, BME, Complutense University of Madrid, Partner, Corporate welfare, RDI

This advancement, fueled by a blend of organic and inorganic growth, surpassed the targets outlined in the budget.

Key Points: 
  • This advancement, fueled by a blend of organic and inorganic growth, surpassed the targets outlined in the budget.
  • Throughout 2020-2023, LLYC has magnified its operating revenues by a factor of 2.1 and its EBITDA by a factor of 2.2.
  • In 2023, LLYC's revenue distribution by business unit was as follows:
    Europe accounted for 33% of operating revenues and 37.7% of EBITDA.
  • In 2023, revenue from innovation activities accounted for 11.4% of Deep Digital's total revenue.

WISeKey Announces Appointment of Jonathan LLamas as VP Decentralized Strategy

Retrieved on: 
Friday, March 8, 2024
Ethereum, Professional, Internet of things, WIHN, Fintech, WKEY, Llama, Business administration, Complutense University of Madrid, Stockholm University, Business school, Cryptocurrency

Geneva, Switzerland, March 08, 2024 (GLOBE NEWSWIRE) -- WISeKey International Holding Ltd. (“WISeKey” or “Company”) (SIX: WIHN, NASDAQ: WKEY), a global leader in cybersecurity, digital identity, and Internet of Things (IoT) innovations, operating as a holding company, today announced the appointment of Jonathan LLamas as VP Decentralized Strategy, effective March 6, 2024.

Key Points: 
  • Geneva, Switzerland, March 08, 2024 (GLOBE NEWSWIRE) -- WISeKey International Holding Ltd. (“WISeKey” or “Company”) (SIX: WIHN, NASDAQ: WKEY), a global leader in cybersecurity, digital identity, and Internet of Things (IoT) innovations, operating as a holding company, today announced the appointment of Jonathan LLamas as VP Decentralized Strategy, effective March 6, 2024.
  • Mr. LLamas joins the team to lead the Company’s ambitions towards its strategic Web 3.0 transition.
  • Mr. LLamas, a serial blockchain entrepreneur and topic expert lecturer at top European Universities, brings nearly two decades of strategic and entrepreneurial experience to WISeKey.
  • Carlos Moreira, Founder and CEO of WISeKey, commented, "I warmly welcome Jonathan to the WISeKey team, where he will be pivotal in advancing our Web 3.0 decentralization strategy.

Shionogi Strengthens Regulatory Leadership with the Appointment of Dr. Ramón Polo as Senior Vice President, Head of Regulatory Affairs

Retrieved on: 
Monday, February 5, 2024
General Health, Health, Science, Research, Oncology, COVID-19, Senior, Management development, Head, Obesity, University of Navarra, Harvard Business School, Inc., Fragile X syndrome, Doctor of Pharmacy, Janssen Pharmaceuticals, Investment, Infection, Hepatitis C, MBA, Regulatory affairs, Master of Science, Complutense University of Madrid, RSV, Acquisition, Vaccine, University, Johnson & Johnson, Pharmaceutical industry

Shionogi Inc., a U.S. subsidiary of Shionogi & Co., Ltd. (Head Office: Osaka, Japan; President and CEO: Isao Teshirogi, Ph.D.; hereinafter “Shionogi”), announced the appointment of Ramón Polo, MBA, PharmD, Ph.D. as Senior Vice President, Head of Regulatory Affairs.

Key Points: 
  • Shionogi Inc., a U.S. subsidiary of Shionogi & Co., Ltd. (Head Office: Osaka, Japan; President and CEO: Isao Teshirogi, Ph.D.; hereinafter “Shionogi”), announced the appointment of Ramón Polo, MBA, PharmD, Ph.D. as Senior Vice President, Head of Regulatory Affairs.
  • He joins Shionogi Inc. from Johnson & Johnson, where he served as the Vice President, Head of Infectious Diseases, Vaccines & Global Public Health Regulatory Affairs.
  • Prior to this, Dr. Polo led the development strategy of treatments for influenza, RSV and hepatitis C at Janssen Pharmaceutical Companies of Johnson & Johnson.
  • Dr. Polo received his PharmD, Master of Science and Ph.D. in Clinical Biochemistry from the Complutense University of Madrid in Spain.

Alvarez & Marsal Expands Its Capital Markets & Accounting Advisory Senior Talent Globally

Retrieved on: 
Tuesday, January 30, 2024
Finance, Consulting, Accounting, Professional Services, Asset Management, Uppsala University, GAAP, Swedish Institute, Partner (business rank), Initial public offering, Capital market, CMAA, TAG, IPO, KPMG, Alvarez and Marsal, Business, Partner, Complutense University of Madrid, Policy studies, Risk, A&M, Financial services

Leading global professional services firm Alvarez & Marsal (A&M) announced the appointment of Stockholm-based Annika Melin Jakobsson and New York-based Patricia Alonso de la Fuente as Global Transaction Advisory Group (TAG) Managing Directors within its Capital Markets & Accounting Advisory (CMAA) practice.

Key Points: 
  • Leading global professional services firm Alvarez & Marsal (A&M) announced the appointment of Stockholm-based Annika Melin Jakobsson and New York-based Patricia Alonso de la Fuente as Global Transaction Advisory Group (TAG) Managing Directors within its Capital Markets & Accounting Advisory (CMAA) practice.
  • Ms. Melin Jakobsson ensures clients’ IPO readiness, and once listed, their alignment with capital markets’ governance, risk and compliance and financial reporting requirements.
  • She focuses on IPOs, acquisitions, divestitures, international financial reporting standards (IFRS), US generally accepted accounting principles (GAAP) conversions and complex technical accounting matters.
  • Prior to joining A&M, Ms. Alonso de la Fuente served with KPMG, most recently as Partner in Deal Advisory in New York, along with leading that firm’s Capital Markets and Accounting Advisory Services US-LatAm corridor.

2023 Brings Rapid Expansion for ITSM Leader EasyVista

Retrieved on: 
Thursday, January 25, 2024
Public Policy, Government, Software, State, Local, Data Management, Technology, University, Apps, Applications, Education, Complutense University of Madrid, Microsoft Power BI, WhatsApp, NAM, ARR, Remote control, Managed services, TIAA, EV, AFJ, ITSM, Workforce, Corporate title, Lead, Green computing, Growth, Management

EasyVista, a global leading provider of ITSM, IT Remote Support and IT Monitoring solutions, experienced another year of rapid growth and expansion—both in terms of ARR and other company initiatives.

Key Points: 
  • EasyVista, a global leading provider of ITSM, IT Remote Support and IT Monitoring solutions, experienced another year of rapid growth and expansion—both in terms of ARR and other company initiatives.
  • In 2023, EasyVista earned the rating of 4.9/5 on the Gartner Peer Insights reviews , with a 95% of users sharing a “willingness to recommend” EasyVista to their peers.
  • These ratings for EasyVista are an increase from 4.7/5 and 83%, respectively, in the 2022 Gartner Peer Insights forum.
  • If 2023, a year of great achievements, is any indication of what’s in store for EasyVista in 2024, the rest of the ITSM industry better watch out.”

LLYC's operating income up 14% to €83.1 MM in 2023

Retrieved on: 
Thursday, January 25, 2024
Region, Learning, BME, Literature, DNA, Knowledge, Human resources, AMP, Hobby, Complutense University of Madrid, Corporate Affairs, Innovation, Corporate finance, Chair, PepsiCo, Education minister, MBA, Market, Acquisition, Harvard Business School, Doctor of Philosophy, Director general, Marketing, General Electric, Energy, Growth, Management

LLYC's performance in 2023 surpassed the objectives outlined in its strategic plan for the year.

Key Points: 
  • LLYC's performance in 2023 surpassed the objectives outlined in its strategic plan for the year.
  • The firm's organic growth led to an 8% increase in operating revenues and gross operating income.
  • It now accounts for 34.5% of operating income and 28.1% of the firm's recurring EBITDA.
  • The new budget forecasts an 8% increase in operating income to 90 million euros and recurring EBITDA to 20 million euros.

Boyden strengthens its team with new partners for leadership consulting

Retrieved on: 
Monday, November 20, 2023
Massachusetts Institute of Technology, Industrial and organizational psychology, Business, Principal, Telecommunications, Research, Alliance Manchester Business School, MIT, University, Certification, Specialization, HR, Complutense University of Madrid, Organizational behavior, Innovation, Insurance, Knowledge, Social policy, Growth, KPMG, Transport, Human resources, Organization, Acceleration, Management

Lisbon, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Marta Santos and Katia Pina have been appointed as the latest partners at Boyden, a global leadership specialist firm, focusing on Leadership Consulting.

Key Points: 
  • Lisbon, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Marta Santos and Katia Pina have been appointed as the latest partners at Boyden, a global leadership specialist firm, focusing on Leadership Consulting.
  • These promotions also align with the growth of the Leadership Consulting area in recent years, both in Portugal and internationally.
  • We proudly congratulate our two new partners," emphasized João Guedes Vaz , Managing Partner, and Global Practice Leader at Boyden Leadership Consulting.
  • With over 20 years of consulting experience, Marta Santos served as Principal at Boyden Leadership Consulting in Portugal since September 2022.

Tilray Medical Supports New Clinical Trial to Study Medical Cannabis in Glioblastoma Cancer Treatment

Retrieved on: 
Monday, October 16, 2023
Partnership, Essential tremor, TSX, Hope, THC, Research, Vomiting, Neuro, Complutense University of Madrid, Radiation, Neuro-Oncology (journal), Safety, HIV, Epilepsy, Teaching hospital, Health, Brain, Clinical trial, International business, Science, Temozolomide, Post-traumatic stress disorder, CBD, Seed bank, Tilray, Neoplasm, Cannabinoid, TLRY, Patient, Pharmaceutical industry, Glioblastoma

Our role in this initiative exemplifies our commitment to medical research, leading us one step closer to unlocking the full therapeutic potential of medical cannabis."

Key Points: 
  • Our role in this initiative exemplifies our commitment to medical research, leading us one step closer to unlocking the full therapeutic potential of medical cannabis."
  • While medical cannabis research has been an ongoing mission towards patient treatment, this trial is unique because it is the culmination of a 10-year civil society collaboration between the scientific sector and the medical cannabis community.
  • With this clinical trial, we can finally study the effect of cannabinoids on tumors that have not received active treatment.
  • Today, with proceeds from the Medical Cannabis Bike Tour founded by Luc Krol from the Netherlands-based cannabis genetics seed bank, Paradise Seeds, the Medical Bike Tour Foundation mobilized the European cannabis community.